WFC
57
-6
BF.B
43
-4
TMO
27
-8
OXY
18
-10
KHC
24
-3
DE
35
-17
PPL
67
-2
TGT
34
-4
AZO
50
-3
FOXA
44
-6
LH
36
-9
ORCL
43
-7
WDC
31
-2
VMC
48
-5
PPG
29
-7
UAL
47
-14
CAG
37
-4
SYK
30
-7
IBM
41
-5
BK
52
-8
WFC
57
-6
BF.B
43
-4
TMO
27
-8
OXY
18
-10
KHC
24
-3
DE
35
-17
PPL
67
-2
TGT
34
-4
AZO
50
-3
FOXA
44
-6
LH
36
-9
ORCL
43
-7
WDC
31
-2
VMC
48
-5
PPG
29
-7
UAL
47
-14
CAG
37
-4
SYK
30
-7
IBM
41
-5
BK
52
-8
Financhill
Back

Ranpak Holdings Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
5

PACK
Ranpak Holdings

Last Price:
$3.74
Seasonality Move:
-12.16%
Sell
48

SRPT
Sarepta Therapeutics

Last Price:
$51.00
Seasonality Move:
12.51%
Sell
5
Ranpak Holdings (PACK) is a Sell

Is Ranpak Holdings a Buy, Sell or Hold?

  • The current Ranpak Holdings [PACK] share price is $3.80. The Score for PACK is 5, which is 90% below its historic median score of 50, and infers higher risk than normal.
  • PACK is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
48
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $50.31. The Score for SRPT is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PACK Stock Price Chart

What is Ranpak Holdings's stock price today?

  • The Ranpak Holdings share price today is $3.80
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PACK is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $50.31
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

PACK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.66 Sell
Relative Strength Index (14 RSI): 28.14 Sell
Chaikin Money Flow: -260290 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.52 - 6.14) Sell
Bollinger Bands (100): (5.65 - 7.71) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -12.43 Sell
Relative Strength Index (14 RSI): 25.41 Sell
Chaikin Money Flow: -2337291 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (57.24 - 93.24) Sell
Bollinger Bands (100): (85.21 - 128.11) Sell

PACK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.3 Sell
20-day SMA: 5.13 Sell
50-day SMA: 6.28 Sell
200-day SMA: 6.66 Sell
8-day EMA: 4.28 Sell
20-day EMA: 4.97 Sell
50-day EMA: 5.81 Sell
200-day EMA: 6.41 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 55.64 Sell
20-day SMA: 68.68 Sell
50-day SMA: 92.51 Sell
200-day SMA: 121.01 Sell
8-day EMA: 56.28 Sell
20-day EMA: 67.87 Sell
50-day EMA: 86.24 Sell
200-day EMA: 111.03 Sell

Ranpak Holdings Earnings Growth & PACK Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.07 per share, and an increase next year of $0.09 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.35 per share, a decrease next quarter of $0.47 per share, an increase this year of $4.58 per share, and an increase next year of $5.49 per share.

Ranpak Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):